Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

nerve-cell-2213009_960_720

Central nervous system cancer metastases – the evolution of diagnostics and treatment

August 4, 2025
CERo therapeutics, Cancer, T cell, immunotherapy

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design

July 11, 2025
Research and Development BioLabs, BioMed X, Cancer, Oncology, Servier, XSeed Labs, antibody therapy, oncology

BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, located at the Spartners incubator …

News

T-cell therapy – the evolution of cancer treatments

July 7, 2025
CERo therapeutics, Cancer, T cell, immunotherapy

The current forms of immunotherapy, how T cell therapy works and what the future holds

Feature

Takeda announces launch of Framework to help support patient access to life-extending combination treatments

February 25, 2025
Business Services Cancer, HIV/AIDS, Immunology, NHS, NICE, Oncology, Takeda, VPAG, patient access

The Conceptual Implementation Framework outlines critical points within the UK healthcare access ecosystem to help improve the introduction of combination …

News
Press release

Research collaboration announced between Oxford University and GSK

January 27, 2025
Research and Development Cancer, Oncology, Oxford University, neoantigens, partnership, research and development

The GSK-Oxford Cancer Immuno-Prevention Programme was announced at the end of January and will focus on researching the prevention of …

News

Third application for Orion’s prostate cancer drug submitted by partner Bayer

September 23, 2024
Bayer, Cancer, Oncology, orion, prostate cancer

Finnish pharmaceutical company Orion has announced that its partner Bayer is applying for a third application of its prostate cancer drug, …

News

ViroCell Biologics signs Master Services Agreement with NCI-designated cancer centre

July 23, 2024
Business Services Cancer, Oncology, ViroCell Biologics, agreement

ViroCell Biologics has announced that it has signed a five-year Master Services Agreement (MSA) with a prominent US-based NCI-designated cancer …

News

OSE Immunotherapeutics and Boehringer Ingelheim collaborate on cancer and cardio-renal-metabolic disease treatments

May 24, 2024
Research and Development Boehringer Ingelheim, Cancer, Cardiology, OSE Immunotherapeutics, cardio-renal-metabolic diseases

OSE Immunotherapeutics and Boehringer Ingelheim have announced a major expansion of their existing partnership. The expansion includes two new projects …

News

Nona Biosciences announced agreement with AstraZeneca for tumour targeted therapies

May 24, 2024
Research and Development AstraZeneca, Cancer, Oncology, nona biosciences, targeted therapies

Nona Biosciences and AstraZeneca have announced that the two companies have entered into a license agreement for preclinical monoclonal antibodies, …

News

Geneos Therapeutics shares data from phase 1/2 trial for cancer vaccine

April 8, 2024
Research and Development Cancer, Geneos Therapeutics, Oncology, clinical trial

Geneos Therapeutics has announced that it has published positive safety, immunogenicity and efficacy data from the full cohort of patients …

News

Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment

March 26, 2024
Research and Development Cancer, Curve Therapeutics, HIF inhibition, Oncology, oncology

Curve Therapeutics has announced that its chief scientific officer, Professor Ali Tavassoli has published research in the Journal of the …

News

Verastem Oncology gains Fast Track Designation for combination NSCLC treatment

January 19, 2024
Medical Communications Cancer, FDA, NSCLC, Oncology, Verastem Oncology

Verastem Oncology has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to the company’s …

News

Astellas and Elpiscience enter collaboration for novel bispecific macrophage engager

January 2, 2024
Research and Development Astellas, Cancer, Elpiscience, Oncology, bispecific macrophage

Elpiscience Biopharma and Astellas Pharma have announced that they have entered into a research collaboration and license agreement for novel …

News
markus-spiske-hvsr_cvecvi-unsplash

Owkin and Merck enter collaboration agreement for AI-powered cancer diagnostics

December 20, 2023
Research and Development AI diagnostics, Cancer, MSD, Merck, Oncology, Owkin

Owkin and Merck, known as MSD outside of the US and Canada, have announced that they have entered into a …

News

Regeneron shares data for multiple myeloma treatment

December 8, 2023
Medical Communications Cancer, Oncology, Regeneron, clinical trial

Regeneron Pharmaceuticals has announced positive data from the pivotal LINKER-MM1 trial which assessed linvoseltamab as a treatment for patients with …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026